within Pharmacolibrary.Drugs.ATC.R;

model R03BA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0025,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.08,
    k12             = 450,
    k21             = 450
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R03BA01</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Beclometasone is a synthetic corticosteroid with potent anti-inflammatory properties, commonly used as an inhaled treatment for asthma and allergic rhinitis. It acts by reducing airway inflammation and bronchial hyperresponsiveness. Beclometasone is approved and widely used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data reported for healthy adult volunteers (both sexes) after inhalation administration.</p><h4>References</h4><ol><li><p>Rony, F, et al., &amp; Klein, J (2024). Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant. <i>Pulmonary pharmacology &amp; therapeutics</i> 85 102299–None. DOI:<a href=\"https://doi.org/10.1016/j.pupt.2024.102299\">10.1016/j.pupt.2024.102299</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38663512/\">https://pubmed.ncbi.nlm.nih.gov/38663512</a></p></li><li><p> (2020). Drugs for COPD. <i>The Medical letter on drugs and therapeutics</i> 62(1606) 137–144. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32960872/\">https://pubmed.ncbi.nlm.nih.gov/32960872</a></p></li><li><p>Kuna, P, et al., &amp; Ciurlia, G (2022). Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma. <i>Pharmacology research &amp; perspectives</i> 10(4) e980–None. DOI:<a href=\"https://doi.org/10.1002/prp2.980\">10.1002/prp2.980</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35733414/\">https://pubmed.ncbi.nlm.nih.gov/35733414</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R03BA01;
